Zydus Cadila Readies Injectables Push

Building Pipeline Amid Tepid US Growth Outlook, As Remdesivir Launches In India

 
• By Vibha Ravi
  
Guidance word in red keyboard buttons
Zydus Cadila Forecasts Tepid Growth In The US • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business